Article Type: Research Article Article Citation: Shoaib Shareef, Sawera Khalil, and Muhammad Shahid Sharif. (2021). CORONAVIRUS
INFECTION AND ITS CONTROL THROUGH VARIOUS APPROACHES: A SHORT REVIEW. International
Journal of Research -GRANTHAALAYAH, 9(3), 97-101. https://doi.org/10.29121/granthaalayah.v9.i3.2021.3769 Received Date: 25 February 2021
Accepted Date: 23 March 2021 Keywords: Coronavirus
Infection Control Various
Approaches Coronavirus is a common virus causing very serious issues to public health. This virus, SARS-COV-2, has disseminated worldwide respiratory illness, designated as COVID-19. This viral infection disturbs people in various ways. A lot of people infested due to this virus develop a mild illness and get relief soon without any sort of hospitalization. But mostly, it becomes highly severe later and the patient has to undergo shortening of breath as well as some other chest-related abnormalities like Middle East Respiratory Syndrome (MERS) and Acute Respiratory Syndrome. In this manuscript, we have discussed multiple areas like symptomatology, management approaches including Homoeopathic and Allopathic (drugs) treatments, plus vaccination. Lastly, we have put in the conclusion of overall literature, and most importantly implicated or suggested certain new research areas for the researchers to explore which may assist in preventing further spread of this threatening syndrome now and in the future.
1. INTRODUCTION1.1. SYMPTOMS OF CORONAVIRUS INFECTIONIn patients with pneumonia caused by
SARS-CoV-2 (new coronavirus pneumonia), the most common indicator or symptom
observed in the patients was fever pursued by cough. The ground-glass opacity
of the lungs was the common judgment from a CT scan of the chest. One of the cases
of SARS-CoV-2 pneumonia in the United States of America is verifying good to Remdesivir, which is still in the trial period in China
(Cheng Lai et al., 2020). There is not merely one coronavirus species but are
the six
that become the source of disease to human such as, common cold, acute
respiratory syndrome as well as the Middle East Respiratory Syndrome. In January
2020, scientists from Wuhan city of China secluded a new coronavirus
(SARS-CoV-2), a causative agent for an upsurge of anonymous pneumonia that had
not been originated in humans earlier. The spreading of this novel coronavirus
takes place through person-to-person contact, respiratory droplets, plus by
touching anything contaminated by the virus. The symptomatology of this viral
infection mostly includes fever, cough, breathing trouble, pneumonia, and severe
acute respiratory syndrome. Those people who are older age and partaking in
poor immunity are at a larger threat of this infection (Ramesh et al., 2020). 2. MANAGEMENT STRATEGIESNumerous defensive approaches, as well as
non-pharmaceutical interventions, are in use to limit the spreading of disease i.e. watchful infection control, the isolation of patients,
and more importantly, is social distancing. Management is chiefly assisting
people with the help of oxygen therapy that is evidencing useful in the
treatment procedure. Moreover, Corticosteroids plus antivirals therapy have
also been verified for a supportive role in critical management strategies
(Nicola et al., 2020). This
disease affected the entire world, and many myths are socializing about its
diagnostic procedures. The option for analysis should be reliant on clinical
and epidemiological factors and associated with an appraisal of the chances of
this viral infection. To detect COVID-19, various speedy diagnostic and
serological tests are in use now. However, the authenticity of such newly
marketed tests is not good enough yet. For that reason, it is not suggested any
such immune chromatographic or serological speedy screening tests to inspect
SARS-CoV-2 contagions. In case to detect COVID-19, PCR (Polymerase Chain
Reaction) is a more reliable and authentic diagnostic test, which is a
molecular-based examination to conform to SARS-CoV-2. Obliteration of highly
transmittable SARS-CoV-2 Virus that is the main source for this newly emerged
deadly pandemic (COVID-19) dictate our attention and understanding is desired
regarding the way as well as a mode of transmission throughout the whole world.
Certain precautionary measures naming as hand-washing,
staying at the home plus upholding the social distance are attested as
effective and instant way-outs to protect humans from this secret enemy (Sajid
and Amgain, 2020). A person having a travel
history from COVID-19 affected countries in the last 14 days or a person whose
COVID-19 test is positive are suspect cases and need evaluation (Ramesh
et al., 2020). 2.1. ROLE OF HOMEOPATHY IN CONTROL OF CORONAVIRUSA wide medical practice has a significant role in the immune-boosting effect of Homoeopathic medicines as well as the hindrance of viral infection. During several disease outbreaks like Cholera, Chikungunya, Japanese Encephalitis, and Dengue Fever, etc. the Genus Epidemicus has been used to control the spread of disease and shows good results. Given the medical achievement in those severe contagious diseases, Homoeopathy as an adjuvant to the standard of care should be evaluated for the administration of COVID-19. The Ministry of Ayurveda, Yoga & Naturopathy, Unani, Siddha, and Homoeopathy (AYUSH) have recommended the use of Arsenicum album-30 for its doable role in stopping the COVID-19 virus (N Parikh and D Parikh., 2020). Antimonium Tart acts directly on mucous membrane producing catarrhal swelling of larynx trachea and bronchi causing amassing of mucous. The Nerve center is affected by this respiratory toxin, causing the severe venous obstruction. By this muscle relaxes and respiration is affected more. It damages the nerves which make emesis…… Dr. W. H. Burt: Physiological Materia Medica (Burt and William H, 1881). In Lecture Notes on Materia Medica, Dr. J.T.Kent says that in Antimonium Tart the beginning of a disease is similar to common upper respiratory tract infection followed by temperature with a dry cough but afterward the disease moves to the lower respiratory portion where a patient doesn’t respond to any other medication Dr. Kent calls this poor response of a person to the disease and in that case the respiratory distress starts. Thus it is very good therapy for poor response where the patient immune system stops working and a lethal rattle in the chest causes death (Boericke, 2020). Dr. William Boericke in his books wrote regarding the antihelminthic characteristics of Antimonium Tart, which stimulates the oxidizing action on the shielding cover of a parasite. The outer layer of the coronavirus also has a lipid coat which can be ruined by Antimonium Tart. Thus we present that Antimonium Tart can be used as a prophylactic and therapeutic involvement in COVID 19 disease based on existing literature and information and its medical use. 2.2. TREATMENT VIA ALLOPATHIC MEDICINE AND VACCINATIONTreatment in coronavirus according to allopathic, included intravenous
infusion of fluid, oxygen therapy, and life support system in serious cases. It
is necessary to contact the doctor immediately if someone has symptoms of the
virus-like flu, fever, and breathlessness. This virus is familiar to the human
immunodeficiency virus (HIV) in terms of virus replication and proteins.
Different managing medicines are present to clear and manage in vitro action in
opposition to SARS-Cov and MERS-Cov (Savarino et
al., 2003). Some drugs being used to get relief from coronavirus infection, and
their functions are discussed (see Table 1 for detail). The two vaccines such
as EUAs – Pfizer-BioNTec and Moderna
- are until now the only products available to Americans. Pfizer’s vaccine is
given by the FDA for people 16 and older, making it the first coronavirus
vaccine presented to the American. The second one is Moderna’s
vaccine that has now been approved for people 18 and older. Both these vaccines
have been found highly effective for preventing COVID-19 in clinical examination
participants. FDA analysis shows that regardless of age, race, or other
risks of serious illness due to infection, Pfizer BioNTech's two-dose vaccine
can effectively resist 95% of COVID-19. And it turns out that Moderna can produce approximately 94.5% of COVID-19 for
people of all ages, genders, and races (Nania
et al,. 2021). Multiple vaccines and their
percentage relief is exhibited below (Fig. 1). Table 1: Multiple allopathic
medicines (drugs) being used to halt deadly coronaviruses
Figure 1: Efficiency or relief of different vaccines (% relief) against coronavirus infection 5. CONCLUSION AND RECOMMENDATIONSCoronavirus
is a contagious disease. From health experts' point of view, it was originated
from bats and later was transmitted to humans. It causes diseases such as
Middle East Respiratory Syndrome and Acute Respiratory Syndrome. Sometimes it
becomes deadly and medical assistance is needed but in many
cases, patients recover without any hospitalization. Six species of
coronavirus are known to cause diseases in humans such as the common cold,
fever, etc. In China, scientists discovered a new coronavirus in January 2020.
This virus was responsible for the outburst of unidentified pneumonia which was
not found in humans before. Its incubation period lies between 2 to14 days.
Seclusion of patients, careful control of disease, and social distancing can
minimize the spread of this disease. Corticosteroids and antiviral therapy are
proving helpful in their control. To detect COVID-19, many tests are in use but
the most reliable test for its detection is PCR (polymerase chain reaction). To
save ourselves from this deadly virus, we should follow safety measures like
proper hand washing, staying at home, and maintaining social distance.
Homeopathy also has a significant role in this pandemic. The homeopathic
medicine Arsenicum album-30 can be proved helpful in
controlling COVID-19. The upper layer of coronavirus is made up of a lipid coat
that can be destroyed by homeopathic medicine named Antimonium
Tart. Allopathic treatment in coronavirus includes an intravenous infusion of
fluid and oxygen therapy. Some vaccines have now also been introduced, such as
Pfizer’s which is given by FDA for people 16 or older. The second one is Moderna’s vaccine which is approved now for use for people
18 or older. By
studying literature, I believe that by boosting immunity we can be protected by
diseases. The immune system is the best because it increases the body’s natural
ability to defend against pathogens. Boosting our immunity, obeying safety
measures such as proper handwashing, avoid close contact with a person who is
sick, avoiding crowded places, and maintaining social distance can help control
Covid-19 infection. The role of homeopathy can help control the virus such as Arsenicum album-30 can help in preventing coronavirus.
Washing our hands frequently with alcohol-based hand wash because it kills the
germs as well as viruses that may be present on our hands. We should cover our
mouth and nose with a bent elbow as well as by tissue during coughing and
sneezing. Clean those surfaces repeatedly which are used regularly. We should
avoid touching our mouth, eyes, and nose. The main point is that by following
good respiratory hygiene, we not only protect ourselves but also other people
from viruses, which cause colds, flue, and COVID-19. There are some areas of research that are not well explored and can be impacted by the COVID-19 in present or in the future. These areas include vaccine development, medication therapy, healthcare and equipment, social, economic, environmental, sustainability, psychiatric, information technology revolution, awareness workshops, biological warfare, and psychological issues. I am certain that if researchers explore these areas and equip each domain with health facilitation then we can halt coronavirus infection to spread worldwide. SOURCES OF FUNDINGThis research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. CONFLICT OF INTERESTThe author have declared that no competing interests exist. ACKNOWLEDGMENTWe thank Mr. Muhammad Zahid
Sharif (a Ph.D. student) for his efforts for multiple revisions and suggestions
to improve this manuscript. REFERENCES [1] Boericke, W. 2020. Homoeopathic Materia
Medica. Retrieved 27 April 2020, from http://www.homeoint.org/books/boericmm/
15. James Tyler Kent. Lectures on Homoeopathic material Medica; Retrieved 28 April, 2020 from
https://homeopathybulgaria.org/todormed/JAMES%20TYLER%20KENTLectures%20ON%20HOMEOPATHIC%20MATERIA
%20MEDICA.pdf [2] Burt, William H. Physiological materia medica, containing all that is known of the
physiological action of our remedies; together with
their characteristic indications and pharmacology. (Chicago, Gross & Delbridge, 1881. [3] Deng, L., Li, C., Zeng, Q., Liu,
X., Li, X., Zhang, H., Hong, Z., Xia, J. (2020). Arbidol
combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A
retrospective cohort study. J. Infect. 81, e1– e5, https://doi.org/10.1016/j.jinf.2020.03.002 [4] Gordon, C.J., Tchesnokov,
Feng, J.Y. (2020). The antiviral compound remdesivir
potently inhibits RNA-dependent RNA polymerase from Middle East respiratory
syndrome coronavirus. Journal of Biological Chemistry. 295: 4773-4779.
https://doi.org/10.1074/jbc.AC120.013056.
[5] Hung, I. F., Lung, K. C., Tso, E.
Y et al. (2020). Triple combination of interferon beta-1b, lopinavir-ritonavir,
and ribavirin in the treatment of patients admitted to hospital with COVID-19:
an open-label, randomised, phase 2 trial. Lancet,
395, 1695– 1704,
https://doi.org/10.1016/S0140-6736(20)31042-4 [6] Kong, R., Yang, G et al. (2020).
COVID-19 docking server: an interactive server for docking small molecules, peptides and antibodies against potential targets of
COVID-19. arXiv preprint
arXiv:2003.00163.https://doi.org/10.1093/bioinformatics/btaa645. [7] Kosyna, F.K., Nagel, M., Kluxen, L. et al. (2015). The importin
α/β-specific inhibitor ivermectin affects HIF-dependent hypoxia
response pathways. Biological Chemistry. 396: 1357-1367.
https://doi.org/10.1515/hsz-2015-0171. [8] Lai, C.C., Shih, T.P., Ko, W.C.,
Tang, H.J. and Hsueh, P.R. (2020). Severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the
epidemic and the challenges. International journal of antimicrobial agents.
105924. [9] Nania,R., Christina, I. and Dena, B.
(2021). What to Know About the Coronavirus Vaccines.
AARP.
https://www.aarp.org/health/conditions-treatments/info-2020/coronavirus-vaccine-research.html [10]
Nicola,
M., O’Neill, N., Sohrabi, C., Khan, M., Agha, M. and
Agha, R. (2020). Evidence based management guideline for the COVID-19 pandemic-review
article. International Journal of Surgery. 77: 206-216. [11]
Parikh,
N. and Parikh, D. (2020). Role of homoeopathy in COVID-19 Management-A clinical
experience. World Journal of Pharmaceutical Research. 9(5): 2459-2466. [12]
Ramesh,
N., Siddaiah, A. and Joseph, B. (2020). Tackling
corona virus disease 2019 (COVID 19) in workplaces. Indian Journal of
Occupational and Environmental Medicine. 24(1): 16-18. [13]
Sajed,
A.N. and Amgain, K. (2020). Corona virus disease
(COVID-19) outbreak and the strategy for prevention. Europasian
Journal of Medical Sciences. 2(1): 1-3. [14]
Shittu
M.O., Afolami O.I. (2020). Improving the efficacy of
chloroquine and hydroxychloroquine against SARS-CoV-2 may require zinc
additives- a better synergy for future COVID-19 clinical trials. Infez Med. 28: 192-197. [15]
Talwar,
S., Sood, S., Kumar, J., Chauhan, R., Sharma, M. and
Tuli, H.S. (2020). Ayurveda and Allopathic Therapeutic Strategies in
Coronavirus Pandemic Treatment 2020. Current pharmacology reports, pp.1-10.s [16]
Wagstaff
K.M, Sivakumaran H, Heaton S.M et al. (2012). Ivermectin is a specific
inhibitor of importin α/β- mediated nuclear importable to inhibit
replication of HIV-1 and dengue virus. Biochemistry Journal. 443: 851-856.
https://doi.org/10.1042/BJ20120150. [17]
Wang
M., Cao, R., Zhang, L et al. (2020). Remdesivir and
chloroquine effectively inhibit the recently emerged novel coronavirus
(2019-nCoV) in vitro. Cell Research. 30: 269-271.
https://doi.org/10.1038/s41422-020-0282-0.
This work is licensed under a: Creative Commons Attribution 4.0 International License © Granthaalayah 2014-2020. All Rights Reserved. |